Coronary artery abnormalities in Hyper-IgE syndrome.
Alexandra F Freeman, Elizabeth Mannino Avila, Pamela A Shaw...
https://pubmed.ncbi.nlm.nih.gov/21494893/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-07-28
600
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying Hyper IgE Syndromes HIES, which are rare immune system disorders causing eczema and repeated skin and lung infections. This includes autosomal dominant HIES caused by STAT3 mutations, which affect multiple body systems like bones, blood vessels, and connective tissue. Another form involves DOCK8 mutations leading to severe viral infections and higher risks of cancer and death. The study aims to better understand these conditions by examining their causes, symptoms, and genetic factors. Participants include patients with confirmed or suspected HIES and their family members. They will undergo extensive clinical and genetic evaluations by a team of specialists and be followed over time. The study collects detailed information to clarify the different types of HIES, identify new genetic causes, and understand how the disease develops and affects the body. During the study, participants will have thorough medical exams, laboratory tests, and immunologic assessments to monitor disease features and quality of life. Researchers will track complications and treatment outcomes as they arise. The study involves long-term follow-up to gather information on disease progression and genetics. Up to 300 patients and 300 relatives are expected to take part in this observational research.
CONDITIONS
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
J
Jean M Ulrick
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
Albert Einstein College of Medicine
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Ongoing long-term
Participants undergo detailed clinical, immunologic, and genetic assessments by a multidisciplinary team. Family members of affected individuals may also be evaluated. Participants are followed over time to understand disease progression and genetics.
Regular visits as scheduled by the study team
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexandra F Freeman, Elizabeth Mannino Avila, Pamela A Shaw...
https://pubmed.ncbi.nlm.nih.gov/21494893/Alexandra F Freeman, Christina J Collura-Burke, Nicholas J Patronas...
https://pubmed.ncbi.nlm.nih.gov/17438082/Alexandra F Freeman, Steven M Holland
https://pubmed.ncbi.nlm.nih.gov/21178271/Steven M Holland, Frank R DeLeo, Houda Z Elloumi...
https://pubmed.ncbi.nlm.nih.gov/17881745/B Grimbacher, S M Holland, J I Gallin...
https://pubmed.ncbi.nlm.nih.gov/10053178/Kathryn J Sowerwine, Steven M Holland, Alexandra F Freeman
https://pubmed.ncbi.nlm.nih.gov/22268731/Alexandra F Freeman, Chen Wang, Amanda Urban...
https://pubmed.ncbi.nlm.nih.gov/42061468/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
Albert Einstein College of Medicine
Collaborating Sponsor